Home
About Us
Investment Approach
Portfolio
Impact
News & Media
Contact
Investor Relations
About Us
Team
Home
About Us
Team
Investment Approach
Portfolio
Impact
News & Media
Contact
Investor Relations
•
By
somerse_wp-capital
•
In
News
•
Tag:
Diagnostics
,
Krsnaa
•
0
Exclusive: Somerset-backed Krsnaa Diagnostics ropes in new private equity investor
Somerset Indus Capital Partners
>
News
>
Exclusive: Somerset-backed Krsnaa Diagnostics ropes in new private equity investor
0
Shares
Diagnostics
Krsnaa
Recent News
Crisil assigns Fund Management Grading – 1 to Somerset Indus Healthcare India Fund III – Scheme I
May 7, 2025
By
somerse_wp-capital
Somerset Bets on Medical Devices Maker “Cyrix Healthcare” In Maiden Deal from Third Fund
December 10, 2024
By
somerse_wp-capital
Impact and Sustainability Report – Somerset Indus Capital – March 2024
October 7, 2024
By
somerse_wp-capital
Tag Cloud
Apex
Browndove
Cygnus
Cyrix
Diagnostics
Digital Health
EICU
Express
Fund
Genworks
Globela
Healthcare Delivery
Hexagon
Hospitals
IPO
Krsnaa
Medical devices
Medtech
Nutrition
Packaging
Pharma
Printmann
Prognosys
Sandor
Somerset
Wellness
Recent Cases
Previous Post
Why govt’s plan to cap prices of more drugs may have a silver lining for investors
Next Post
IndiaMedToday
Related Posts
August 11, 2021
Krsnaa Diagnostics: Taking the Indian Healthcare Paradigm to the Next Level
By
somerse_wp-capital
In
News
0
May 18, 2021
Krsnaa Diagnostics files IPO papers with Sebi
By
somerse_wp-capital
In
News
0
December 4, 2020
Company watch: Krsnaa Diagnostics suffers expansion pangs but poised for virus boom
By
somerse_wp-capital
In
News
0
